RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment

Cost Eff Resour Alloc 19(1):50 · 2021 · PMID 34391439

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

35편 검색→32편 판독→10편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Cost-effectiveness of amyloid PET imaging in mild cognitive impairment and early Alzheimer disease diagnosis (("Cost-Effectiveness Analysis"[MeSH Terms] OR "cost-effectiveness"[tiab] OR "cost effectiveness"[tiab] OR "economic evaluation"[tiab] OR "cost-benefit"[tiab] OR "cost utility"[tiab]) AND ("Positron-Emission Tomography"[MeSH Terms] OR "amyloid PET"[tiab] OR "amyloid positron emission tomography"[tiab] OR "PET imaging"[tiab] OR "florbetapir"[tiab] OR "florbetaben"[tiab] OR "flutemetamol"[tiab] OR "PiB PET"[tiab]) AND ("Cognitive Dysfunction"[MeSH Terms] OR "mild cognitive impairment"[tiab] OR "MCI"[tiab] OR "Alzheimer Disease"[MeSH Terms] OR "Alzheimer*"[tiab] OR "early diagnosis"[tiab]))

출판 연도

2015: 1편120152017: 1편120202021: 1편12023: 1편12025: 4편42026: 2편22026

선별된 10편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01treatment · positron emission5편

  1. 0.95

    Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer's disease - the case of florbetapir

    Hornberger J, Bae J, Watson I et al. · Current medical research and opinion · 2017

  2. 0.93

    Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment 이 논문

    Lee YS, Youn H, Jeong HG et al. · Cost effectiveness and resource allocation : C/E · 2021

  3. 0.91

    The Value of Positron Emission Tomography for Confirmation of Alzheimer's Disease in the Era of Amyloid-Targeting Therapies

    Veljanoska E, Gomes S, Szende A et al. · Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2025

  4. 0.90

    Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal Perspective

    Hornberger J, Michalopoulos S, Dai M et al. · The journal of mental health policy and economics · 2015

  5. 0.59

    Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting

    Wimo A, Handels R, Blennow K et al. · Journal of Alzheimer's disease : JAD · 2025

02approach · confidence5편

  1. 0.93

    Utility, Costs and Cost-Utility of Amyloid-PET in the Diagnostic Process of Memory Clinic Patients: A Trial-Based Economic Evaluation From AMYPAD-DPMS

    van Maurik IS, Altomare D, Collij LE et al. · European journal of neurology · 2025

  2. 0.90

    Cost-effectiveness of Alzheimer's disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis

    Contador J, Vargas-Martinez AM, Sanchez-Valle R et al. · European archives of psychiatry and clinical neuroscience · 2023

  3. 0.88

    Long-term cost-effectiveness of a more accurate diagnostic work-up for dementia

    van der Veere PJ, Broulikova HM, Hoogland J et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2025

  4. 0.66

    GRAD: A Two-Stage Algorithm for Resolving Diagnostic Uncertainty in the Plasma p-tau217 Gray Zone

    Parankusham H, Krishna E · medRxiv : the preprint server for health sciences · 2026

  5. 0.55

    Cost-effectiveness analysis of blood-based biomarker testing in the diagnosis of Alzheimer's disease pathology

    Li Y, Lagier RJ, Racke MK et al. · The journal of prevention of Alzheimer's disease · 2026